Anavex Life Sciences Corp (AVXL)

[Investor2014]

That’s why I hope that the presentation 25th will put that doubt to rest.

The possibility of misdiagnosis and no placebo control in a small trial is good reason why the market so far is not too impressed.

The science and totally of information that we are all aware of is why I see Anavex as one the best risk/reward ratios I know of at present. Getting into an Anavex position in 6 months to 2 years from now could turn out significantly more expensive.